Global C-Reactive Protein (CRP) ELISA Kit Market Strategic Research Report

Scope of the Report

The global C-Reactive Protein (CRP) ELISA Kit market size is predicted to grow from US$ 64.82 million in 2025 to US$ 101 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

C-Reactive Protein (CRP) ELISA Kit is a finished immunoassay kit based on enzyme-linked immunosorbent assay technology for quantitative measurement of CRP in human, mouse, rat, canine, porcine, and other biological samples. Typical formats include pre-coated sandwich ELISA kits, high-sensitivity CRP ELISA kits, rapid ELISA kits, and uncoated assay development kits. The product is mainly used in inflammation research, infection models, cardiovascular and metabolic studies, drug development, animal experiments, translational medicine, and hospital research platforms. Upstream inputs mainly include CRP capture antibodies, detection antibodies, recombinant CRP standards, enzyme conjugates, pre-coated microplates, blocking buffers, wash buffers, chromogenic substrates, stop solutions, sample diluents, stabilizers, packaging materials, and cold-chain logistics. Downstream customers mainly include academic laboratories, hospital research centers, pharmaceutical companies, biotechnology companies, contract research laboratories, animal research centers, and selected clinical research institutions. On an ex-factory finished-kit basis, excluding standalone antibodies, protein raw materials, ELISA plate readers, testing services, and CRP rapid test strips, global capacity in 2025 is estimated at about 360,000 units, with sales volume of about 231,700 units and an average ex-factory selling price of around USD 286 per unit. The global industry gross margin is estimated at approximately 45%–68%.

The global market is composed of research reagent brands, life science reagent groups, specialized ELISA suppliers, and regional biological reagent companies. Demand is mainly concentrated in academic research, hospital research platforms, drug development, animal model studies, and translational medicine. Compared with routine clinical CRP testing, CRP ELISA kits are more focused on experimental research and small-batch quantitative sample analysis, so the market places greater emphasis on assay validation, lot-to-lot stability, sample compatibility, and complete product documentation. U.S. and European brands remain strong in publication records, validation data, channel coverage, and high-end research customers, while Chinese and other Asian suppliers are improving their competitiveness in pricing, delivery time, species coverage, and customized service. Future market development will continue to move toward higher sensitivity, faster workflow, lower sample volume, and broader species coverage. Pre-coated sandwich ELISA kits will remain the mainstream format, but rapid ELISA kits, high-sensitivity ELISA kits, single-wash formats, and more stable standard systems will gradually improve laboratory efficiency. Research users are placing increasing importance on reproducibility, standard curve linearity, recovery, dilution linearity, and lot-to-lot consistency. Suppliers that can provide clear quality-control data, detailed instructions, and responsive technical support are more likely to secure repeat purchases. Product competition will shift from catalog breadth alone to validation quality, application data, and customer support capability. Market growth is mainly driven by sustained investment in inflammation and immune disease research, cardiovascular and metabolic studies, infection and sepsis models, drug safety evaluation, animal model experiments, and biomarker research. As a classic acute-phase protein, CRP has high research awareness, mature experimental protocols, and broad sample compatibility, making it a basic marker in inflammation-related studies. With pharmaceutical companies and research institutions increasing investment in translational medicine, mechanism research, and early efficacy evaluation, standardized ELISA kits will continue to have stable demand, especially in single-marker quantification, small-batch sample validation, and multi-species model research. Key restraints include high product homogeneity, a large number of suppliers, increasing price transparency, and insufficient validation among some low-cost products. Some brands rely on OEM supply or channel distribution, which can create differences in product origin, lot consistency, and after-sales response, affecting long-term customer trust. At the same time, multiplex assay platforms, automated immunoassay systems, and high-throughput protein detection technologies may divert part of the high-end research demand. The market is expected to concentrate gradually around two types of companies: large reagent groups with global brands, strong validation systems, and high-end customer bases, and specialized suppliers with cost advantages, fast delivery, and broad niche species coverage.

Key Questions Addressed in this Report

What is the 10-year outlook for the global C-Reactive Protein (CRP) ELISA Kit market?

What factors are driving C-Reactive Protein (CRP) ELISA Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do C-Reactive Protein (CRP) ELISA Kit market opportunities vary by end market size?

How does C-Reactive Protein (CRP) ELISA Kit break out by Type, by Application?

This report presents a comprehensive overview of the global C-Reactive Protein (CRP) ELISA Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Pre-coated Sandwich ELISA Kit
• High-sensitivity ELISA Kit
• Other

Segment by Species Reactivity

• Human
• Mouse
• Rat
• Other

Segment by Kit Size

• 48 Tests
• 96 Tests
• 192 Tests and Above
• Other

Segment by Application

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global C-Reactive Protein (CRP) ELISA Kit market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact